Eloxx Pharmaceuticals's total assets for Q1 2026 were $8.50M, an increase of 40.73% from the previous quarter. ELOX total liabilities were $16.09M for the fiscal quarter, a -38.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.